HUYABIO International
Ning Li is a highly experienced professional in the biotech and pharmaceutical industry, currently holding the position of Sr. Director, Portfolio at HUYABIO International. Prior to this, Ning served in various roles at companies such as Novasite Pharmaceuticals and Polgenix Inc. With a Ph.D. in Biochemistry from Baylor College of Medicine and a B.S. in Molecular Biology from the University of Science and Technology of China, Ning has a strong academic background to support their career success.
HUYABIO International
HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.